Annual report pursuant to Section 13 and 15(d)

Balance Sheet Components

v3.20.4
Balance Sheet Components
12 Months Ended
Dec. 31, 2020
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Balance Sheet Components

NOTE 6—BALANCE SHEET COMPONENTS

Accrued liabilities comprise the following (in thousands):

 

 

 

December 31,

2020

 

 

December 31,

2019

 

Accrued liabilities:

 

 

 

 

 

 

 

 

General and administrative

 

$

1,577

 

 

$

4,521

 

Clinical trial related costs

 

 

1,743

 

 

 

1,383

 

Non-clinical research and manufacturing operations

 

 

4,321

 

 

 

5,774

 

Payroll related

 

 

4,908

 

 

 

2,849

 

Other accrued expenses

 

 

26

 

 

 

17

 

Total Accrued liabilities

 

$

12,575

 

 

$

14,544

 

 

 

         Other current liabilities comprise the following (in thousands):

 

 

 

December 31,

2020

 

 

December 31,

2019

 

Other Current liabilities:

 

 

 

 

 

 

 

 

Finance Lease Liability, current portion

 

 

1

 

 

 

18

 

Long Term Debt, Current Portion

 

 

 

 

 

800

 

Operating Lease Liability, current portion

 

 

2,210

 

 

 

1,683

 

Total Other Current liabilities

 

$

2,211

 

 

$

2,501